Savara Inc SVRA Stock Analysis
- Nasdaq
- Stock
- Market open · no trades yet today
$4.66 down $0.09, 1.89% at close Nov 4
Last close · Previous close $4.75
- Market cap
- At the Nov 4 close
- P/E ratio
- On last 12 months’ EPS
- Diluted EPS
- Last 12 months
- Dividend yield
- NoneLast 12 months
Price chart
$4.66down $0.09, 1.89%Wed, Nov 4 session
Use the left and right arrow keys to move along the chart.
Price data
Trading
- Previous close$4.75Nov 3
- Volume3.56MNov 4 session
Shares traded on all US exchanges in the last completed session. Live intraday volume covers IEX only, so it is left out.
- Avg. volume2.43MLast 21 sessions
The average daily shares traded over the last 21 trading sessions, about one calendar month.
- 52-week range: $3.86 to $7.01; now $4.66
The lowest and highest trades over the past 52 weeks, adjusted for splits. The marker shows the latest price.
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
Performance
Past performance, measured to the Nov 4 close. Total return includes reinvested dividends.Price change only, without dividends. Compared with the S&P 500, using SPY.
SVRA beat the S&P 500 in 1 of 7 periods.
| Period | SVRA and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | SVRA: down 3.1% S&P 500: down 0.4% | SVRA trailed the S&P 500 by 2.7 percentage points Trailed |
| 3M | SVRA: down 13.9% S&P 500: down 0.3% | SVRA trailed the S&P 500 by 13.6 percentage points Trailed |
| YTD | SVRA: down 22.7% S&P 500: up 13.3% | SVRA trailed the S&P 500 by 36.0 percentage points Trailed |
| 1Y | SVRA: up 12.8% S&P 500: up 14.8% | SVRA trailed the S&P 500 by 2.0 percentage points Trailed |
| Long term | ||
| 3Y | SVRA: up 23.0% S&P 500: up 82.9% +7.1% vs +22.3% a year | SVRA trailed the S&P 500 by 59.9 percentage points Trailed |
| 5Y | SVRA: up 282.0% S&P 500: up 75.6% +30.7% vs +11.9% a year | SVRA beat the S&P 500 by 206.4 percentage points Beat |
| 10Y | SVRA: down 15.1% S&P 500: up 330.8% −1.6% vs +15.7% a year | SVRA trailed the S&P 500 by 345.9 percentage points Trailed |
$10,000 invested in SVRA 10 years ago (Nov 4, 2016) would be worth about $8,491 at the close on , with dividends reinvested. The same amount in the S&P 500 would be worth about $43,084.
SVRA beat the S&P 500 in 1 of 7 periods.
| Period | SVRA and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | SVRA: down 3.1% S&P 500: down 0.4% | SVRA trailed the S&P 500 by 2.7 percentage points Trailed |
| 3M | SVRA: down 13.9% S&P 500: down 0.6% | SVRA trailed the S&P 500 by 13.3 percentage points Trailed |
| YTD | SVRA: down 22.7% S&P 500: up 12.4% | SVRA trailed the S&P 500 by 35.1 percentage points Trailed |
| 1Y | SVRA: up 12.8% S&P 500: up 13.6% | SVRA trailed the S&P 500 by 0.8 percentage points Trailed |
| Long term | ||
| 3Y | SVRA: up 23.0% S&P 500: up 76.4% +7.1% vs +20.8% a year | SVRA trailed the S&P 500 by 53.4 percentage points Trailed |
| 5Y | SVRA: up 282.0% S&P 500: up 64.2% +30.7% vs +10.4% a year | SVRA beat the S&P 500 by 217.8 percentage points Beat |
| 10Y | SVRA: down 15.1% S&P 500: up 267.7% −1.6% vs +13.9% a year | SVRA trailed the S&P 500 by 282.8 percentage points Trailed |
$10,000 invested in SVRA 10 years ago (Nov 4, 2016) would be worth about $8,491 at the close on , not counting dividends. The same amount in the S&P 500 would be worth about $36,769.
All-time high
$9,240.00
Closing high on . Now 99.9% below that record.
Split-adjusted daily closes since Apr 29, 2004.
Stock splits
2
Latest: 1-for-70 on . Share counts adjust after each split.
Both splits
- 1-for-70
- 1-for-25
Valuation
Financials
About Savara Inc
Savara is a clinical-stage biopharmaceutical company focused on rare respiratory diseases. Our lead program, MOLBREEVI*, is a recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (autoimmune PAP). MOLBREEVI is delivered via an investigational eFlow ® Nebulizer System (PARI Pharma GmbH) specifically developed for inhalation of a large molecule. Our management team has significant experience in rare respiratory diseases and pulmonary medicine, identifying unmet needs, and effectively advancing product candidates to approval and commercialization.
- Sector
- Industry
- Headquarters
- Exchange
- Nasdaq
- Asset type
- Common stock
- Price history since
SVRA news
Explore more stocks
Prices are from the last refresh. Open any stock for its live dashboard.
Popular stocks
SVRA stock FAQ
What is SVRA stock’s price today?
Savara (SVRA) traded at $4.66 at the close on , down $0.09 (1.89%) from the previous close of $4.75. Over the past 52 weeks it has traded between $3.86 and $7.01.
If you invested $1,000 in SVRA 10 years ago, how much would you have now?
With dividends reinvested, $1,000 invested in SVRA on would be worth about $849 at the close on , a total return of −15.1%. The same $1,000 would be worth $3,820 if invested five years ago, $1,128 if invested one year ago, and $1 if invested 20 years ago. Past performance doesn’t predict future returns.
Does SVRA pay a dividend?
Savara hasn’t paid a dividend in the last twelve months.
What is SVRA’s 52-week high and low?
Over the past 52 weeks SVRA has traded as low as $3.86 and as high as $7.01. At $4.66 at the close on , it is 33.5% below that high and 20.7% above the low.
What is SVRA’s all-time high?
SVRA’s highest closing price was $9,240.00 on , adjusted for stock splits. At $4.66 at the close on , it is 99.9% below that record.
Has SVRA stock ever split?
Yes, twice: 1-for-25 on ; 1-for-70 on .
How has SVRA stock performed?
Including dividends and measured to the close on , SVRA has returned −22.7% so far this year and +12.8% over the past year, and +282.0% over five years (+30.7% a year). Over the same periods the S&P 500, measured by SPY, returned +13.3%, +14.8% and +75.6%. Past performance doesn’t predict future returns.
What exchange does SVRA trade on?
Savara trades on the Nasdaq under the ticker symbol SVRA. Its price history on this dashboard begins on .
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
About this data. Data sourced by Tiingo (opens in a new tab). The live price is Tiingo’s real-time price, based on IEX trades and quotes; intraday charts show IEX trades, and volume figures are consolidated totals for completed sessions. Prices are split-adjusted, and total returns assume dividends are reinvested. Financials come from company filings and can lag new reports. Times are Eastern.
This page is for education, not investment advice. Past performance doesn't predict future returns. Logos provided by Logo.dev (opens in a new tab).
The Interactive Brokers word and logo are trademarks of Interactive Brokers LLC (or its subsidiaries) in the US and/or elsewhere. All rights reserved.